 Plants have long been known for their potential as sources of anti-cancer drugs. Recently, researchers have developed novel nanoparticles derived from plant-based materials and artificial membrane hybrids to improve the delivery of anti-cancer drugs. These nanoparticles have shown promise in in vitro and in vivo studies, suggesting that they could be used to treat cancer more effectively than current methods. This article was authored by Sarah Baldassari, Alice Balboni, Julianna Drava, and others.